Citation: | Jing ZHANG, Zhi-yong LIANG, Jie GAO, Tong-hua LIU. Relationship between the Mutations of Epidermal Growth Factor Receptor Gene and k-ras Gene and the Clinicopathological Features of Non-small Cell Lung Cancers[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(1): 53-59. |
[1] |
Travis WD, Brambilla E, Muller-Hermelink HK, et al. World Health Organization classification of tumors.Pathology and genetics tumors of the lung, plrura, thymus and heart [M].Lyon:IARC Press, 2004:12-15.
|
[2] |
Jemal A, Siegel R, Ward E, et al.Cancer Statistics, 2006 [J].CA Cancer J Clin, 2006, 56:106-130. DOI: 10.3322/canjclin.56.2.106
|
[3] |
Scagliotti GV, Selvaggi G, Novello S, et al.The biology of epidermal growth factor receptor in lung cancer[J].Clin Cancer Res, 2004, 10:4227-4232. DOI: 10.1158/1078-0432.CCR-040007
|
[4] |
Fukuoka M, Yano S, Giaccone G, et al.Multiinstitutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer[J].J Clin Oncol, 2003, 21:2237-2246. DOI: 10.1200/JCO.2003.10.038
|
[5] |
Kris MG, Natale RB, Herbst RS, et al.Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer:a randomized trial[J].JAMA, 2003, 290: 2149-2158. DOI: 10.1001/jama.290.16.2149
|
[6] |
Paez JG, Janne PA, Lee JC, et al.EGFR mutations in lung cancer:correlation with clinical response to gefitinib therapy [J].Science, 2004, 304:1497-1500. DOI: 10.1126/science.1099314
|
[7] |
Lynch TJ, Bell DW, Sordella R, et al.Activating mutations in the epidermal growth factor recepto runderlying responsiveness of non-small-cell lung cancer to gefitinib[J].N Engl J Med, 2004, 350:2129-2139. DOI: 10.1056/NEJMoa040938
|
[8] |
Shigematsu H, Lin L, Takahashi T, et al.Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers[J].J Natl Cancer Inst, 2005, 97:339-346. DOI: 10.1093/jnci/dji055
|
[9] |
张静, 梁智勇, 曾瑄, 等.应用蝎形探针扩增阻滞突变系统检测非小细胞肺癌表皮生长因子受体基因突变与病理改变的关系[J].中华病理学杂志, 2008, 37:294- 299. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhblx200805002
|
[10] |
Graziano SL, Gamble GP, Newman NB, et al.Prognostic significance of k-rascodon 12 mutations in patients with resected stage Ⅰ and Ⅱ non-small-cell lung cancer[J].J Clin Oncol, 1999, 17:668-675. DOI: 10.1200/JCO.1999.17.2.668
|
[11] |
Massarelli E, Varella-Garcia M, Tang X, et al.KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer[J].Clin Cancer Res, 2007, 13:2890-2896. DOI: 10.1158/1078-0432.CCR-06-3043
|
[12] |
Fujno S, Enokibori T, Tezuka N, et al.A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer[J].Eur J Cancer, 1996, 32A, 2070-2074. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1097/CJI.0000000000000300
|
[13] |
Bell DW, Lynch TJ, Haserlat SM, et al.Epidermal growth factor receptor mutations and gene amplification in nonsmall-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials[J].J Clin Oncol, 2005, 23:8081- 8092. DOI: 10.1200/JCO.2005.02.7078
|
[14] |
Masaki T, Shiniehi T, Katsuyuki K, et al.The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non small cell lung cancers[J]. Clin Cancer Res, 2005, 11:1167-1173. http://jjco.oxfordjournals.org/cgi/ijlink?linkType=ABST&journalCode=clincanres&resid=11/3/1167
|
[15] |
张晓彤, 李龙芸, 王树兰, 等.吉非替尼治疗晚期非小细胞肺癌疗效观察[J].中华结核和呼吸杂志, 2005, 28:180-183. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhjhhhx200503010
|
[16] |
Sanford M, Scott LJ.Gefitinib:a review of its use in the treatment of locally advanced/metastatic non-small cell lung cancer[J].Drugs, 2009, 69:2303-2328. DOI: 10.2165/10489100-000000000-00000
|
[17] |
Kalikaki A, Koutsopoulos A, Hatzidaki D, et al.Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and k-ras mutation status[J].Lung Cancer, 2010, 69:110-115. DOI: 10.1016/j.lungcan.2009.09.010
|
[18] |
Slebos RJ, Kibbelaar RE, Dalesio O, et al.k-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung[J].N Engl J Med, 1990, 323:561-565. DOI: 10.1056/NEJM199008303230902
|
[19] |
Massarelli E, Varella-Garcia M, Tang X, et al.KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer[J].Clin Cancer Res, 2007, 13:2890-2896. DOI: 10.1158/1078-0432.CCR-06-3043
|
[20] |
Linardou H, Dahabreh IJ, Kanaloupiti D, et al.Assessment of somatic k-ras mutations as a mechanism associated with resistance to EGFR-targeted agents:a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer[J].Lancet Oncol, 2008, 9:962-972. DOI: 10.1016/S1470-2045(08)70206-7
|
[21] |
Kosaka T, Yatabe Y, Endoh H, et al.Mutations of the epidermal growth factor receptor gene in lung cancer:biological and clinical implications[J]. Cancer Res, 2004, 64: 8919-8923. DOI: 10.1158/0008-5472.CAN-04-2818
|
[22] |
Planchard D, Loriot Y, Besse B.Impac t of KRAS in standard treatment of non-smallcell lung cancer(NSCLC) patients in 2009:prognostic and predictive value[J].Bull Cancer, 2009, 96:S57-S68.
|
[1] | YAO Ru, YANG Xu, QU Yang, LIAN Jie, ZHANG Jiahui, HUANG Xin, CHEN Chang, REN Xinyu, PAN Bo, ZHOU Yidong, SUN Qiang. PTEN Mutation Related Unilateral Multicentric, Synchronous and Metachronous Bilateral Breast Cancer: Three Case Reports[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 916-920. DOI: 10.12290/xhyxzz.2023-0550 |
[2] | CHEN Yuqing, LI Jinming. Virological Characteristics of the Omicron Variant: Key Mutations, Pathogenicity, and Immune Escape[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 945-952. DOI: 10.12290/xhyxzz.2023-0139 |
[3] | QIU Luyao, TANG Wenjing, YANG Lu, LYU Ge, CHEN Junjie, SUN Gan, WANG Yanping, ZHOU Lina, AN Yunfei, ZHANG Zhiyong, TANG Xuemei, ZHAO Xiaodong, DU Hongqiang. Clinical Phenotype and Immunological Characteristics of A Patient with De Novo Heterozygous Mutation of PTEN[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 373-378. DOI: 10.12290/xhyxzz.2023-0023 |
[4] | MAIMAITI Nu-rong-gu-li, Hua-bing ZHANG, Xiao-ping XING. Clinical and Genetic Analysis of a Uyghur Patient with Gitelman's Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 427-431. DOI: 10.3969/j.issn.1674-9081.2015.06.006 |
[5] | Jing ZHANG, Jie GAO, Sha-fei WU, Tao LU, Zhi-yong LIANG. Clinicopathological Features and Epidermal Growth Factor Receptor Gene Status of Adrenocortical Oncocytic Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 191-196. DOI: 10.3969/j.issn.1674-9081.2015.03.006 |
[6] | Ming-yang LIU, Jie CHEN, Jian GUAN. Local Injections of Cholesterol-conjugated let-7a Mimics Inhibit Tumor Growth and Metastasis of Hepatocellular Carcinoma in a Subcutaneous Xenograft Nude Mouse Model by Targeting K-Ras, H-Ras, and N-Ras[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(2): 133-139. DOI: 10.3969/j.issn.1674-9081.2015.02.012 |
[7] | Bei TAN, Yun-lu FENG, Dong WU, Yi-cheng ZHU, Yu CHEN, Jia-ming QIAN. Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by A Novel TYMP Gene Mutation in An Adult Patient[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(3): 302-306. DOI: 10.3969/j.issn.1674-9081.2014.03.011 |
[8] | Fei XU, Rui-fang SUI, Hui LI, Ru-xin JIANG, Fang-tian DONG. Clinical Characteristics and Genetic Mutations of Chinese Patients with X-linked Retinoschisis[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 98-103. DOI: 10.3969/j.issn.1674-9081.2013.02.003 |
[9] | Xu ZHANG, Yong-sheng TIAN, Xiao-wei CHEN, Hong JIANG. Mitochondrial 12S rRNA Mutations Related to Drug-induced Hearing Loss[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(2): 185-189. DOI: 10.3969/j.issn.1674-9081.2012.02.012 |
[10] | Shuang-ni YU, Yun-xiao MENG, Yi-hui MA, Zhao-hui LU, Jie CHEN. Regulatory Effects of Let-7a and miR-96 Molecules on K-RAS in Pancreatic Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 26-29. DOI: 10.3969/j.issn.1674-9081.2012.01.007 |
1. |
梁婵,周君燕,李岚梅,陈凤珍. 消化内镜预约诊疗的研究进展. 当代护士(上旬刊). 2023(03): 14-17 .
![]() |